Cost-effectiveness of percutaneous image-guided core breast biopsy

Seminars in Breast Disease

Volumn 4, Issue 2, 2001, Pages 68-77

  Liberman, L ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST BIOPSY; BREAST LESION; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC VALUE; FEMALE; HUMAN; IMAGING; MODEL; PERCUTANEOUS BIOPSY; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; REVIEW; SURGICAL TECHNIQUE;

EID: 0034900461     PISSN: 10924450     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Percutaneous image-guided core breast biopsy: State of the art at the millennium
2. The role of cost-effectiveness analysis in health and medicine. Panel on cost-effectiveness in health and medicine
3. Recommendations of the panel on cost-effectiveness in health and medicine
4. Recommendations for reporting cost-effectiveness analyses. Panel on cost-effectiveness in health and medicine
5. Evaluating the cost-effectiveness of clinical and public health measures
6. Needle core biopsy guided with mammography: A study of cost effectiveness
7. Estimating the cost-effectiveness of stereotactic biopsy for nonpalpable breast abnormalities: A decision analysis model
8. Cost-effectiveness of MR imaging and core-needle biopsy in the preoperative work-up of suspicious breast lesions
9. Stereotactic breast biopsy with a biopsy gun
10. Nonpalpable breast lesions: Stereotactic automated large-core biopsies
11. Nonpalpable breast lesions: Correlation of stereotactic large-core needle biopsy and surgical biopsy results
12. Breast biopsy: A comparative study of stereotaxically guided core and excisional techniques
13. Impact of stereotaxic core biopsy on cost of diagnosis
14. Cost-effectiveness of stereotactic core needle biopsy: Analysis by means of mammographic findings
15. The Breast Imaging Reporting and Data System: Positive predictive value of mammographic features and final assessment categories
16. BI-RADS categorization as a predictor of malignancy
17. Stereotactic core biopsy of impalpable spiculated breast masses
18. Stereotactic core biopsy of calcifications highly suggestive of malignancy
19. Nonpalpable, probably benign lesions: Role of follow-up mammography
20. Periodic mammographic follow-up of probably benign lesions: Results of 3,184 consecutive cases
21. Surveillance mammography and stereotactic core breast biopsy for probably benign lesions: A cost comparison analysis
22. Stereotactic breast biopsy as an alternative to open excisional biopsy
23. Role of stereotactic biopsy in assessment of nonpalpable breast lesions
24. Mammographically detected breast cancer: Benefits of steretactic core versus wire localization biopsy
25. Stereotactic core biopsy reduces the reexcision rate and the cost of mammographically detected cancer
26. Open versus stereotactic breast biopsy
27. Selective use of image-guided large-core needle biopsy of the breast: Accuracy and cost-effectiveness
28. Stereotactic and ultrasound core needle breast biopsy performed by surgeons
29. Core-needle and surgical breast biopsy: Comparison of three methods of assessing cost
30. Impact of core biopsy on the surgical management of impalpable breast cancer: Another look at margins
31. Impact of core biopsy on the surgical management of impalpable breast cancer
32. Benefits of diagnosing nonpalpable breast cancer with stereotactic large-core needle biopsy: Lower costs and fewer operations
33. Large-core needle biopsy of nonpalpable breast cancers: The impact on subsequent surgical excisions
34. Clinical management issues in percutaneous core breast biopsy
35. Stereotactic breast biopsy: Improved tissue harvesting with the mammotome
36. Cost-effectiveness of stereotactic 11-gauge directional vacuum-assisted breast biopsy
37. Tissue marking clip for stereotactic breast biopsy: Initial placement accuracy, long-term stability, and usefulness as a guide for wire localization
38. Clip placement after stereotactic vacuum-assisted breast biopsy
39. US-guided automated large-core breast biopsy
40. Ultrasound-guided core breast biopsy: Utility and cost-effectiveness
41. Advanced Breast Biopsy Instrumentation (ABBI): Analysis of published experience